ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "pediatrics and vasculitis"

  • Abstract Number: 1289 • 2017 ACR/ARHP Annual Meeting

    Assessing ACR/EULAR Provisional 2017 Classification Criteria for Granulomatosis with Polyangiitis (GPA) in a Cohort of 376 Children with Small to Medium Vessel Chronic Vasculitis – a Pediatric Vasculitis Initiative (PedVas) Study

    Angelyne Rivera1, Kimberly Morishita2, David Cabral2 and Raashid Luqmani3, 1Pediatrics, BC Children's Hospital and University of British Columbia, Vancouver, BC, Canada, 2BC Children's Hospital and University of British Columbia, Vancouver, BC, Canada, 3Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom

     Background/Purpose: Classification of chronic vasculitis to clinically or etiologically meaningful groups has been challenging.  In 2008, the 1990 ACR classification criteria for GPA was adapted…
  • Abstract Number: 1754 • 2017 ACR/ARHP Annual Meeting

    Childhood- Vs. Adult-Onset ANCA-Associated Vasculitides: A Nested, Matched Case–Control Study from the French Vasculitis Study Group Registry

    Michele Iudici1, Christian Pagnoux2, Pierre Quartier3, Mathias Büchler4, Ramiro Cevallos5, Pascal Cohen6, Claire de Moreuil7, Philippe Guilpain8, Alain Le Quellec8, Jacques Serratrice9, Benjamin Terrier6, Claire Le Jeunne6, Loïc Guillevin1, Luc Mouthon10 and Xavier Puéchal for the French Vasculitis Study Group1, 1National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France, 2Mount Sinai Hospital, Toronto, ON, Canada, 3Necker-Enfants Malades Hospital, Paris, France, 4Tours, Tours, France, 5Strasbourg, Strasbourg, France, 6Service de Médecine Interne, Hôpital Cochin, Centre de référence national pour les maladies systémiques autoimmunes rares d’Ile de France, DHU Authors, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France, Paris, France, 7CHU de Brest, Brest, France, 8Montpellier, Montpellier, France, 9Marseille, Marseille, France, 10Service de Médecine Interne, Hôpital Cochin, Centre de référence national pour les maladies systémiques autoimmunes rares d’Ile de France, DHU Authors, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France ;Université Paris Descartes Sorbonne Paris, Paris, France

    Background/Purpose: ANCA-associated vasculitides (AAVs) are potentially life-threatening diseases rarely observed in childhood. Whether AAVs in children (cAAVs) differ from adult-onset AAVs (aAAVs) is still not…
  • Abstract Number: 2937 • 2017 ACR/ARHP Annual Meeting

    Genetic Variants in HLA-C and Class I Pathway Genes Influence Susceptibility to Kawasaki Disease

    Chisato Shimizu1, Jihoon Kim2, Hariklia Eleftherohorinou3, Victoria Wright3, Long Hoang4, Adriana Tremoulet5, Alessandra Franco6, Martin Hibberd4, Atsushi Takahashi7,8, Michiaki Kubo9, Kaoru Ito10, Toshihiro Tanaka10,11, Yoshihiro Onouchi10,12, Lachlan Coin3, Michael Levin3, Jane Burns13 and Hiroko Shike14, 1Pediatrics, University of California San Diego, School of Medicine, La Jolla, CA, 2Medicine, University California San Diego, School of Medicine, Division of Biomedical Informatics, La Jolla, CA, 3Imperial College London, London, United Kingdom, 4Genome Institute of Singapore, Singapore, Singapore, 5Pediatrics, University California San Diego, School of Medicine, La Jolla, CA, 6Pediatrics, University of California San Diego School of Medicine, La Jolla, CA, 7Laboratory for Statistical Analysis, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan, 8Department of Genomic Medicine, National Cerebral And Cardiovascular Center, Suita, Japan, 9RIKEN Center for Integrative Medical Sciences, Yokohama, Japan, 10Laboratory for Cardiovascular Diseases, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan, 11Department of Human Genetics and Disease Diversity, Graduate School of Medical and Dental Sciences, Tokyo, Japan, 12Department of Public Health, Chiba University Graduate School of Medicine, Chiba, Japan, 13Pediatrics, University California San DIego, School of Medicine, San Diego, CA, 14Penn State Hershey Medical Center, Hershey, PA

    Background/Purpose: Host genetics influence susceptibility to Kawasaki disease (KD), an acute pediatric vasculitis, and genome wide association studies (GWAS) have detected variants with modest effects…
  • Abstract Number: 2963 • 2016 ACR/ARHP Annual Meeting

    BehçEt’s Disease in Children: Eastern Mediterranean Experience

    Hafize Emine Sonmez1, Ezgi Deniz Batu1, Betul Sozeri2, Yonatan Butbul Aviel3, Yelda Bilginer4 and Seza Ozen5, 1Pediatric Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey, 2Pediatric Rheumatology, Erciyes University Faculty of Medicine, Kayseri, Turkey, 3Pediatric Rheumatology, Rambam Medical Center, Haifa, Israel, 4Department of Pediatrics, Division of Rheumatology, Hacettepe University Faculty of Medicine, ANKARA, Turkey, 5Department of Pediatrics, Division of Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey

    Background/Purpose: Behçet’s disease (BD) is a variable vessel vasculitis which is more common in adults. The most widely used diagnostic criteria for adult onset disease…
  • Abstract Number: 2427 • 2015 ACR/ARHP Annual Meeting

    Long-Term Efficacy and Safety of Mycophenolate Mofetil in Childhood Primary Central Nervous System Vasculitis

    Alice Brambilla1, Alessandra Cosi2, Anna Rosati2, Renzo Guerrini2, Rolando Cimaz1 and Gabriele Simonini1, 1Pediatric Rheumatology, Pediatric Rheumatology Unit, Anna Meyer Children's Hospital-University of Florence, Firenze, Italy, 2Neurology Unit, Neurology Unit, Anna Meyer Children's Hospital-University of Florence, Firenze, Italy

    Background/Purpose: Childhood primary central nervous system vasculitis (cPANCS) is an inflammatory brain disease targeting either small (angiography-negative) or medium-large (angiography-positive) central nervous system vessels. Vascular…
  • Abstract Number: 1452 • 2015 ACR/ARHP Annual Meeting

    Pauciimmune and Immune Mediated Pulmonary Capillaritis in Children

    Jennifer Soares1,2, Gail Deutsch2,3, BreAnna Kinghorn2 and Anne M. Stevens4, 1Pediatric Pulmonary and Sleep Division, Seattle Children's Hospital, Seattle, WA, 2School of Medicine, University of Washington, Seattle, WA, 3Pathology, Seattle Children's Hospital, Seattle, WA, 4Seattle Children's Res Inst, Seattle Children's Hospital, Seattle, WA

    Background/Purpose: Immune mediated and pauciimmune pulmonary capillaritis are rare causes of diffuse alveolar hemorrhage and associated childhood diffuse lung disease.  As such ideal therapies and…
  • Abstract Number: 2278 • 2014 ACR/ARHP Annual Meeting

    Orbital Pseudotumor As the Presenting Symptom of Pediatric ANCA-Associated Vasculitis

    Amanda Schlefman1, Maureen Leffler2, AnneMarie C. Brescia3 and Carlos D. Rose4, 1A.I. DuPont Hospital for Children, Wilmington, DE, 2Rheumatology, AI duPont Hospital for Children, Wilmington, DE, 3Pediatric Rheumatology, Thomas Jefferson University/ AI duPont Hospital for Children, Wilmington, DE, 4Pediatrics, Division of Rheumatology, Nemours A.I. duPont Hospital for Children, Thomas Jefferson University, Wilmington, DE

    Background/Purpose: Ocular involvement, particularly orbital pseudotumor, has been reported as the initial manifestation of ANCA-associated vasculitis (AAV) in the adult population, predominantly in granulomatosis with…
  • Abstract Number: 296 • 2012 ACR/ARHP Annual Meeting

    A Brazilian Multicenter Study of 71 Children and Adolescents with Takayasu’s Arteritis

    Maria Teresa Terreri1, Gleice Clemente2, Clovis Silva3, Silvana Sacchetti4, Adriana M. Sallum5, Lucia M. A. Campos6, Maria Carolina Santos4, Flavio Sztajnbok7, Rozana Gasparello de Almeida8, Virginia P. Ferriani9, Blanca E. Bica10, Teresa Robazzi11, Marcia Bandeira12, Andre Cavalcanti13, Marise Lessa14, Sheila K. Feitosa de Oliveira15 and Maria Odete Hilario16, 1Pediatrics, Universidade Federal de São Paulo / UNIFESP, Sao Paulo, Brazil, 2Pediatrics, Universidade Federal de São Paulo/UNIFESP, São Paulo, Brazil, 3Pediatric Rheumatology, MD; PhD, São Paulo-SP, Brazil, 4Pediatrics, Santa Casa de Misericórdia de São Paulo, São Paulo, Brazil, 5Pediatric Rheumatology Unit, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo-SP, Brazil, 6Pediatric Rheumatology, University of São Paulo Medical School, São Paulo, Brazil, 7PRINTO, Genoa, Italy, 8Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil, 9Pediatrics, FMUSP-Ribeirao Preto, Ribeirao Preto, Brazil, 10International Investigator Consortium for MAS Diagnostic Criteria, Rio de Janeiro, Brazil, 11Pediatrics, Universidade Federal da Bahia, Salvador, Brazil, 12Pediatrics, Hospital Infantil Pequeno Príncipe, Curitiba, Brazil, 13Universidade Federal de Pernambuco, Recife, Brazil, 14Pediatrics, Instituto de Pediatria e Puericultura Martagão Gesteira (IPPMG) da Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil, 15Pediatric Rheumatology, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil, 16Pediatrics, Universidade Federal de Sao Paulo / UNIFESP, Sao Paulo, Brazil

    Background/Purpose: Takayasu’s arteritis is a chronic granulomatous disease that affects the vascular wall of the large arteries and can result in end organ damage. It…
  • Abstract Number: 274 • 2012 ACR/ARHP Annual Meeting

    Childhood Onset Angiitis of the Central Nervous System: What Outcomes Can We Expect?

    Lena Das1, Sook Fun Hoh2, Terrence Thomas3 and Thaschawee Arkachaisri4, 1Pediatric Rheumatology, KK Women's and Children's Hospital, Singapore, Singapore, 2Nursing, KK Women's and Children's Hospital, Singapore, Singapore, 3Pediatric Neurology, KK Women's and Children's Hospital, Singapore, Singapore, 4Rheumatology & Immunology, KK Women's and Children's Hospital and Duke-NUS Graduate Medical School, Singapore, Singapore

    Background/Purpose: Imaging findings in large-medium vessel Childhood Onset Primary and Secondary Angiitis of the Central Nervous System (cPACNS & cSACNS) are well described, however, structural…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology